Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19

Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19

The SARS-CoV-2 virus emerged in December 2019 in Wuhan, China and then spread rapidly all over the world. Scientists are intensifying their research efforts in order to find antivirals specific to the virus and vaccines to treat or prevent COVID-19. Now, for a medicative cure for COVID-19, several d...

書誌詳細
第一著者:	Amrit Krishna Mitra
フォーマット:	論文
言語:	English
出版事項:	AIMS Press 2020-12-01
シリーズ:	AIMS Molecular Science
主題:	covid-19 sars-cov-2 chloroquine hydroxychloroquine lopinavir ritonavir remdesivir favipiravir vitamin c convalescent plasma
オンライン･アクセス:	http://www.aimspress.com/article/10.3934/molsci.2020012?viewType=HTML

類似資料

Review of Clinical Trials in COVID-19: Trying to Solve the Clinicians’ Conundrum
著者:: Amita Athavale, 等
出版事項: (2020-07-01)

COVID-19: An Update about the Discovery Clinical Trial
著者:: Jean Jacques Vanden Eynde
出版事項: (2020-05-01)

Therapeutic Strategies in the Management of COVID-19
著者:: Rajashri R. Naik, 等
出版事項: (2021-02-01)

A narrative review of antiviral drugs used for COVID-19 pharmacotherapy
著者:: Subodh Kumar, 等
出版事項: (2021-01-01)

COVID-19: A Brief Overview of the Discovery Clinical Trial
著者:: Jean Jacques Vanden Eynde
出版事項: (2020-04-01)

A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking
著者:: Achal Mishra, 等
出版事項: (2021-06-01)

COVID-19 possible medical treatments
著者:: Marzieh Mohammadi, 等
出版事項: (2021-01-01)

Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)
著者:: Abhi Bhadra, 等
出版事項: (2020-05-01)

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
著者:: Shahamah Jomah, 等
出版事項: (2020-09-01)

Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
著者:: Sultan Ayoub Meo, 等
出版事項: (2020-10-01)

Comparison of effectiveness of various treatment strategies in COVID-19 patients: A Systematic Review
著者:: Muhammad Shehryar Hussain, 等
出版事項: (2020-08-01)

Pharmacological management of COVID-19
著者:: Veena Raghunathan, 等
出版事項: (2020-01-01)

An early assessment of the efficacy of medicines in the treatment of patients with COVID-19
著者:: A. S. Kolbin
出版事項: (2020-05-01)

Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19
著者:: B. K. Romanov
出版事項: (2020-09-01)

Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
著者:: Xinni Xu, 等
出版事項: (2020-05-01)

The Rationale for Potential Pharmacotherapy of COVID-19
著者:: Maha Saber-Ayad, 等
出版事項: (2020-05-01)

Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
著者:: Qomara WF, 等
出版事項: (2021-11-01)

Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
著者:: Milo Gatti, 等
出版事項: (2021-02-01)

Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study
著者:: David Grimaldi, 等
出版事項: (2020-10-01)

COVID-19 treatment in children: A systematic review and meta-analysis
著者:: Prateek Kumar Panda, 等
出版事項: (2021-01-01)

Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
著者:: Alina Kröker, 等
出版事項: (2021-11-01)

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
著者:: Stanković Biljana, 等
出版事項: (2020-01-01)

Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series
著者:: Hayato Koba, 等
出版事項: (2020-12-01)

Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
著者:: Abubakar AR, 等
出版事項: (2020-12-01)

Clinical evaluation of selected Pharmacological Treatments used for Coronavirus (COVID-19) pandemic
著者:: hasan mohammed altemimy
出版事項: (2020-06-01)

Efficacy of lopinavir/ritonavir plus interferon beta compared to hydroxychloroquine in the treatment of COVID-19: A retrospective observational study
著者:: Motahareh Amirizadeh, 等
出版事項: (2023-01-01)

High Prevalence of Potential Drug-Drug Interactions Among Patients Treated with Off-label Therapies for COVID-19
著者:: Allan Ramos-Esquivel, 等
出版事項: (2022-06-01)

Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents
著者:: Shagun B Shah, 等
出版事項: (2021-01-01)

Progress in the Research and Development of Anti-COVID-19 Drugs
著者:: Lianzhou Huang, 等
出版事項: (2020-07-01)

A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial
著者:: A. Abayomi, 等
出版事項: (2021-12-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
著者:: Muhammad Haroon Aftab, 等
出版事項: (2024-01-01)

Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
著者:: Mehdi Hassaniazad, 等
出版事項: (2020-10-01)

Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
著者:: Woon Yi Law, 等
出版事項: (2020-11-01)

The Effectiveness of Hydroxychloroquine Versus Hydroxychloroquine Plus Lopinavir/Ritonavir Therapy in SARSCoV- 2 Pneumonia
著者:: Ayşe BATIREL, 等
出版事項: (2021-12-01)

Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
著者:: Min Joo Choi, 等
出版事項: (2021-01-01)

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial
著者:: Justin T. Denholm, 等
出版事項: (2020-07-01)

Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations
著者:: Paolo Gaibani, 等
出版事項: (2021-03-01)

Cardiotoxic Drugs Used in the Treatment of COVID-19
著者:: A. S. Zmitrukevich, 等
出版事項: (2024-01-01)

Determination of lopinavir/ritonavir concentrations in four different oral solutions for the application of antiretroviral therapy in very young, HIV-1-infected children
著者:: Nils von Hentig, 等
出版事項: (2021-05-01)

Scoping insight on antiviral drugs against COVID-19
著者:: Ahmed S. Ali, 等
出版事項: (2021-10-01)